Ignite Creation Date:
2025-12-25 @ 12:38 AM
Ignite Modification Date:
2025-12-25 @ 10:48 PM
Study NCT ID:
NCT06229067
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-01-29
First Post:
2024-01-19
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Efficacy and Safety of PD-L1 Monoclonal Antibody Combined With Metronomic VEX in Advanced Triple-negative Breast Cancer
Sponsor:
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-01-19
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-01-19
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-01-19
Completion Date Type:
ESTIMATED
First Submit Date:
2024-01-19
First Submit QC Date:
None
Study First Post Date:
2024-01-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-01-19
Last Update Post Date:
2024-01-29
Last Update Post Date Type:
ACTUAL